59 related articles for article (PubMed ID: 11687599)
1. Disease-Associated Risk Variants in
Davari DR; Orlow I; Kanetsky PA; Luo L; Edmiston SN; Conway K; Parrish EA; Hao H; Busam KJ; Sharma A; Kricker A; Cust AE; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Ollila DW; Begg CB; Berwick M; Thomas NE;
Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2309-2316. PubMed ID: 34607836
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.
McWilliams RR; Wieben ED; Rabe KG; Pedersen KS; Wu Y; Sicotte H; Petersen GM
Eur J Hum Genet; 2011 Apr; 19(4):472-8. PubMed ID: 21150883
[TBL] [Abstract][Full Text] [Related]
3. A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds.
Lang JM; Shennan M; Njauw JC; Luo S; Bishop JN; Harland M; Hayward NK; Tucker MA; Goldstein AM; Landi MT; Puig S; Gruis NA; Bergman W; Bianchi-Scarra G; Ghiorzo P; Hogg D; Tsao H
J Invest Dermatol; 2011 Feb; 131(2):480-6. PubMed ID: 21085193
[TBL] [Abstract][Full Text] [Related]
4. A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL).
Harland M; Goldstein AM; Kukalizch K; Taylor C; Hogg D; Puig S; Badenas C; Gruis N; ter Huurne J; Bergman W; Hayward NK; Stark M; Tsao H; Tucker MA; Landi MT; Scarra GB; Ghiorzo P; Kanetsky PA; Elder D; Mann GJ; Holland EA; Bishop DT; Bishop JN;
Eur J Cancer; 2008 Jun; 44(9):1269-74. PubMed ID: 18394881
[TBL] [Abstract][Full Text] [Related]
5. Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma.
Cotignola J; Reva B; Mitra N; Ishill N; Chuai S; Patel A; Shah S; Vanderbeek G; Coit D; Busam K; Halpern A; Houghton A; Sander C; Berwick M; Orlow I
BMC Med Genet; 2007 Mar; 8():10. PubMed ID: 17346338
[TBL] [Abstract][Full Text] [Related]
6. In-depth mutation and SNP discovery using DHPLC gene scanning.
Lilleberg SL
Curr Opin Drug Discov Devel; 2003 Mar; 6(2):237-52. PubMed ID: 12669460
[TBL] [Abstract][Full Text] [Related]
7. The use of denaturing high performance liquid chromatography (DHPLC) for mutation scanning of hereditary cancer genes.
Marsh DJ; Howell VM
Methods Mol Biol; 2010; 653():133-45. PubMed ID: 20721741
[TBL] [Abstract][Full Text] [Related]
8. Validation of denaturing high performance liquid chromatography as a rapid detection method for the identification of human INK4A gene mutations.
Orlow I; Roy P; Barz A; Canchola R; Song Y; Berwick M
J Mol Diagn; 2001 Nov; 3(4):158-63. PubMed ID: 11687599
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of denaturing high performance liquid chromatography for the mutational analysis of the MEN1 gene.
Crépin M; Pigny P; Escande F; Bauters CC; Calender A; Lefevre S; Buisine MP; Porchet N; Odou MF
J Mol Endocrinol; 2006 Apr; 36(2):369-76. PubMed ID: 16595707
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
[TBL] [Abstract][Full Text] [Related]
11. Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations.
Liu W; Smith DI; Rechtzigel KJ; Thibodeau SN; James CD
Nucleic Acids Res; 1998 Mar; 26(6):1396-400. PubMed ID: 9490783
[TBL] [Abstract][Full Text] [Related]
12. NF1 gene analysis based on DHPLC.
De Luca A; Buccino A; Gianni D; Mangino M; Giustini S; Richetta A; Divona L; Calvieri S; Mingarelli R; Dallapiccola B
Hum Mutat; 2003 Feb; 21(2):171-2. PubMed ID: 12552569
[TBL] [Abstract][Full Text] [Related]
13. A high-throughput denaturing high-performance liquid chromatography method for the identification of variant alleles associated with dihydropyrimidine dehydrogenase deficiency.
Ezzeldin H; Okamoto Y; Johnson MR; Diasio RB
Anal Biochem; 2002 Jul; 306(1):63-73. PubMed ID: 12069415
[TBL] [Abstract][Full Text] [Related]
14. Sequencing of beta 2-adrenoceptor gene PCR products using Taq BigDye terminator chemistry results in inaccurate base calling.
Humma LM; Farmerie WG; Wallace MR; Johnson JA
Biotechniques; 2000 Nov; 29(5):962-4, 966, 968 passim. PubMed ID: 11084855
[No Abstract] [Full Text] [Related]
15. Malignant melanoma: prevention, early detection, and treatment in the 21st century.
Rigel DS; Carucci JA
CA Cancer J Clin; 2000; 50(4):215-36; quiz 237-40. PubMed ID: 10986965
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
